Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices

Journal of Neurochemistry

Volumn 73, Issue 2, 1999, Pages 641-646

  King, Peter J ^a,c   Widdowson, Peter S ^a   Doods, Henri N ^b   Williams, Gareth ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c Diabet and Endocrinol Res Unit   (United Kingdom)

Author keywords

Autoreceptors; Calcium channels; Neuropeptide Y; Y2 receptors; Y4 receptors

Indexed keywords

AUTORECEPTOR; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y [13-36]; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y2 RECEPTOR; NIFEDIPINE; OMEGA AGATOXIN; OMEGA CONOTOXIN GVIA; PANCREAS POLYPEPTIDE; POTASSIUM;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; ENERGY BALANCE; HYPOTHALAMUS; MALE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

ANIMALS; ARGININE; AUTORECEPTORS; BIOLOGICAL TRANSPORT; CALCIUM CHANNEL BLOCKERS; HYPOTHALAMUS; LIGANDS; MALE; NAPHTHALENES; NEUROPEPTIDE Y; NIFEDIPINE; OMEGA-CONOTOXIN GVIA; OMEGA-CONOTOXINS; ORGAN CULTURE TECHNIQUES; PEPTIDE FRAGMENTS; PEPTIDES; PEPTIDES, CYCLIC; POTASSIUM; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE Y; SPIDER VENOMS;

ANIMALIA; MAMMALIA; TRIXIS;

EID: 0032801628     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0730641.x     Document Type: Article

References (39)

1. Adrian T. E., Allen J. M., Bloom S. R., Ghatei M. A., Rossor M. N., Roberts G. A., Crow T. J., Tatemoto K., and Polak J. (1983) Neuropeptide Y distribution in human brain. Nature 306, 584-586.
2. Allen Y. S., Adrian T. E., Allen J. M., Tatemoto K., Crow T. J., Bloom S. R., and Polak J. M. (1983) Neuropeptide Y distribution in the rat brain. Science 223, 877-879.
3. Bai F. L., Yamano M., Shiotani Y., Emson P. C., Smith A. D., Powell J. F., and Tohyama M. (1985) The arcuate-paraventricular and dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res. 331, 172-175.
4. Bard J. A., Walker M. W., Branchek T. A., and Weinshank R. L. (1995) Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J. Biol. Chem. 270, 26762-26765.
5. Billington C. J., Briggs J., Grace M., and Levine A. S. (1991) Effects of intracerebroventricular injection of NPY on energy metabolism. Am. J. Physiol. 260, R321-R327.
6. Brady L. S., Smith M. A., Gold P. W., and Herkenham M. (1990) Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 52, 441-447.
7. Broberger C., Landry M., Wong H., Walsh J. N., and Hökfelt T. (1997) Subtypes of Y1 and Y2 of neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology 66, 393-408.
8. Broberger C., Johansen J., Johansson C., Schalling M., and Hökfelt T. (1998) The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc. Natl. Acad. Sci. USA 95, 15043-15048.
9. Chance W. T., Balasubramanian A., Thompson H., Mohapatra B. V., Ramo J., and Fischer J. E. (1996) Assessment of feeding response of tumor-bearing rats to hypothalamic injection and infusion of neuropeptide Y. Peptides 17, 797-801.
10. 5 receptor. J. Clin. Invest. 102, 2136-2145.
11. Currie P. J. and Coscina D. V. (1995) Dissociated feeding and hypothermic effects of neuropeptide Y in the paraventricular and perifornical hypothalamus. Peptides 16, 599-604.
12. Dryden S., Pickanave L., Frankish H., Wang Q., and Williams G. (1995) Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res. 690, 185-188.
13. 2 receptors in the rat brain. Eur. J. Pharmacol. 191, 501-503.
14. 3-36 binding sites in rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands. Synapse 22, 139-158.
15. Egawa M., Yoshimatsu H., and Bray G. A. (1991) Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue. Am. J. Physiol. 260, R328-R334.
16. 3H]BIBP3226. Eur. J. Pharmacol 278, 239-242.
17. 2 receptors in rat and guinea-pig brains. Neuroscience 76, 215-224.
18. 34-PYY is a high affinity radioligand for rat PP1/Y4 and Y1 receptors: evidence for heterogeneity in pancreatic polypeptide receptors. Peptides 18, 397-401.
19. Gerald C., Walker M. W., Criscione L., Gustafson E. L., Batzl-Hartmann C., Smith K. E., Vaysse P., Durkin M. M., Laz T. M., Linemeyer D. L., Schaffhauser A. O., Whiteshank S., Hofbauer K. G., Taber R. I., Branchek T. A., and Weinshank R. L. (1996) A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382, 168-171.
20. Grouzmann E., Buclin T., Martire M., Cannizzaro C., Dorner B., Razaname A., and Mutter M. (1997) Characterization of a selective antagonist of neuropeptide Y at the Y2 receptor. Synthesis and pharmacological evaluation of a Y2 antagonist. J. Biol. Chem. 272, 7699-7706.
21. 3 receptors. Eur. J. Pharmacol. 278, R3-R5.
22. King P. J. and Williams G. (1998) Role of ARC NPY neurons in energy balance. Drug News Perspect. 11, 402-410.
23. Larsen P. J., Sheikh S. P., Jakobsen C. R., Schwartz T. W., and Mikkelsen J. D. (1993) Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system. Eur. J. Neurosci. 5, 1622-1637.
24. Maggi C. A., Patacchini R., Santicioli P., Lippe I., Giulini S., Geppetti P., Del Bianco E., Selleri S., and Meli A. (1988) The effect of omega conotoxin GVIA, a peptide modulator of the N-type voltage sensitive calcium channels, on motor responses produced by activation of efferent and sensory nerves. Naunyn Schmiedebergs Arch. Pharmacol. 338, 107-113.
25. Matthews J. E., Jansen M., Lyerly D., Cox R., Chen W.-J., Koller K. J., and Daniels A. J. (1997) Pharmacological characterization and selectivity of the NPY antagonist GR231118 (1229U91) for different NPY receptors. Regul. Pept. 72, 113-119.
26. Meister B., Ceccatelli S., Hökfelt T., Anden N.-E., Anden M., and Theodorsson E. (1989) Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions. Exp. Brain Res. 76, 343-368.
27. Moga M. M. and Saper C. B. (1994) Neuropeptide-immunoreactive neurons projecting to the paraventricular hypothalamic nucleus in the rat. J. Comp. Neurol. 346, 137-150.
28. 2) receptor. Eur. J. Pharmacol. 267, 253-262.
29. Sahu A., Kalra P. S., and Kalra S. P. (1988) Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides 9, 83-86.
30. Schaffhauser A. O., Stricker-Kongrad A., Brumner L., Cumin F., Gerald C., Whitebread S., Criscione L., and Hofbauer K. G. (1997) Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligonucleotides. Diabetes 46, 1792-1798.
31. Stanley B. G., Kyrhouli S. E., Lampert S., and Leibowitz S. F. (1986) Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 7, 1189-1192.
32. Stanley B. G., Magdalin W., Seirafi A., Nguyen M. M., and Leibowitz S. F. (1996) Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a variant of the Y1 receptor mediating this peptide's effect. Peptides 13, 581-587.
33. Vettor R., Zarjevski N., Cusin I., Rohner-Jeanrenaud F., and Jeanrenaud B. (1994) Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia 37, 1202-1208.
34. Walker M. W., Smith K. E., Bard J., Vaysse P. J.-J., Gerald C., Daouti S., Weinshank R. L., and Branchek T. A. (1997) A structure-activity analysis of the cloned rat and human Y4 receptors for pancreatic polypeptide. Peptides 18, 609-612.
35. Waterman S. A. (1997) Role of N-, P-, and Q-type voltage-gated calcium channels in transmitter release from sympathetic neurones in the mouse isolated vas deferens. Br. J. Pharmacol. 120, 393-398.
36. 5 NPY receptors. Brain Res. 778, 242-250.
37. Wieland H. A., Engel W., Eberlein K., Rudolf K., and Doods H. N. (1998) Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents. Br. J. Pharmacol. 125, 549-555.
38. Wright C. E. and Angus J. A. (1996) Effects of N-, P-, and Q-type neuronal calcium channel antagonists on mammalian peripheral neurotransmission. Br. J. Pharmacol. 119, 49-56.
39. Zarjevski N., Cusin I., Vettor R., Rohner-Jeanrenaud F., and Jeanrenaud B. (1993) Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133, 1753-1758.